Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
22.33
-0.31 (-1.37%)
At close: Jun 18, 2026, 4:00 PM EDT
22.33
0.00 (0.01%)
After-hours: Jun 18, 2026, 4:24 PM EDT
Pacira BioSciences Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Pacira BioSciences stock has a consensus rating of "Buy" and an average price target of $29.67. The average 1-year stock price forecast is 32.87% higher than the current stock price, while the lowest is $23 (+3.00%) and the highest is $38 (+70.17%).
Price Target: $29.67 (+32.87%)
Analyst Consensus: Buy
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Pacira BioSciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $25 | Hold | Maintains | $25 | +11.96% | May 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $38 | Buy | Reiterates | $38 | +70.17% | May 4, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 1, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $22 → $24 | Hold | Maintains | $22 → $24 | +7.48% | May 1, 2026 |
| Needham | Needham | Buy Maintains $30 → $32 | Buy | Maintains | $30 → $32 | +43.30% | May 1, 2026 |
Financial Forecast
Revenue This Year
767.79M
from 726.41M
Increased by 5.70%
Revenue Next Year
831.29M
from 767.79M
Increased by 8.27%
EPS This Year
2.88
from 2.65
Increased by 8.57%
EPS Next Year
3.65
from 2.88
Increased by 26.79%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 769.0M | ||
| Avg | 767.8M | ||
| Low | 766.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.9% | ||
| Avg | 5.7% | ||
| Low | 5.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.98 | ||
| Avg | 2.88 | ||
| Low | 2.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.5% | ||
| Avg | 8.6% | ||
| Low | 3.3% |